GOSS · NASDAQ · Biotechnology

Gossamer Bio (GOSS)

Develops inhaled seralutinib for pulmonary arterial hypertension and PH-ILD.

$11.70
After hours−0.10 (−0.85%)
At close$11.80(+4.61%)